polycythaemia despite repeated falls in arterial oxyghaemoglobin saturation (Sao2) during six to eight hours of sleep. These patients provide a model for studying the characteristics of erythropoietin release in response to intermittent severe hypoxaemia in man.
Methods
Eight men with newly diagnosed and untreated obstructive sleep apnoea underwent all night sleep studies. Four of the patients had daytime hypoxaemia (arterial oxygen tension (Pao2) less than 10 kPa) and two had airflow obstruction with a forced expiratory volume in one second (FEV,) (2, 3, 4, 8) had samples taken for measurement of serum erythropoietin concentrations while they were awake before (21.00-22.00 hours) and after the sleep study (10.00-12.00 hours). There was no significant difference in the values (mean (SD) 15 2 (7 3) and 14 6 (5-1) mU/ml).
There was no significant correlation between mean overnight erythropoietin concentration or any of the following measures of Sao2; mean Sao2 (r = 017), nfean Sao2 at arousal (r = 0 30), mean Sao2 between episodes of apnoea (r = 0 21), total hypoxic dose (r = 0 12), lowest Sao2 (r = 0 18). There was no significant increase in erythropoietin overnight with time. There was also no significant correlation between the areas under the curves for Sao2 against time or for serum erythropoietin concentrations against time (analysis of variance: R2 -0 138; F = 0 962, p < 0 25).
Discussion
Erythropoietin production in response to induced hypoxia has been investigated in animals but cannot readily be studied in man. Patients with obstructive sleep apnoea have recurrent spontaneous episodes of severe hypoxaemia and offer a human model for the study of erythropoietin secretion. Our results showed no relation between serum erythropoietin concentration and oxyhaemoglobin saturation.
We measured serum erythropoietin using a modification of a well established radioimmunoassay method5 that was both sensitive and reliable. Samples were taken at appropriate times to detect a rise in erythropoietin, as this has been reported to begin after as little as one hour of hypoxaemia in animal models. 4 We do not believe that we missed bursts of secretion initiated by each individual apnoeic episode: the plasma half life of endogenous erythropoietin is at least three hours,' and we took samples as frequently as every five minutes in patient 5 (for two hours) and hourly in the rest. We postulated that there might be a cumulative effect secondary to night time hypoxaemia, but neither morning nor evening erythropoietin concentrations were significantly raised, which supports previous findings in patients with chronic obstructive lung disease.3 There was no significant difference between pre-study and post-study concentrations of erythropoietin (evening and morning), suggesting an absence of diurnal variation in our subjects. Early evidence was against the presence of diurnal variation in erythropoietin concentrations,6 apart from one report on a single subject.7
Recent work using the more sensitive radioimmunoassay showed clear evidence of diurnal variation in serum erythropoietin in 27 patients in hospital8 and these results have subsequently been repeated (P J Gomes, personal communication). The lack of diurnal variation in our patients with obstructive sleep apnoea Erythropoietin concentrations in obstructive sleep apnoea contrasts with these findings and may be explained by the disruption of sleep by cyclical hypoxaemia and consequent arousal. An alternative explanation would be that our subjects remained awake during their studies. As we did not perform electroencephalography to stage sleep we do not have documentary evidence to refute this suggestion; but the observations of our experienced sleep laboratory staff and the pattern of the oximetry recordings are against it.
A direct relation between the degree of hypoxaemia and erythropoietin concentrations has been described,' but despite falls in Sao2 to ,below 50% in four patients we could detect no such change. Possibly our patients had adapted to their nocturnal hypoxaemia, as normal individuals do at altitude. In these circumstances there is an initial rise in erythropoietin but secretion then falls to within the normal range,2 though polycythaemia is maintained. The patients in our study were not polycythaemic, which would seem to argue against this "adaptive" explanation. Longer episodes of constant rather than episodic hypoxaemia may be required to initiate erythropoietin secretion and increase red cell mass, such as occur in the "overlap" syndrome of obstructive sleep apnoea and chronic obstructive lung disease.9 It is, however, puzzling that only half of patients with chronic obstructive lung disease and polycythaemia have raised erythropoietin concentrations.3 Perhaps, as in normal individuals exposed to hypoxia, this is due to down regulation of erythropoietin secretion after an initial rise.' 2 None of our patients was polycythaemic, though four had some degree of daytime hypoxaemia. It therefore seems probable that sustained nocturnal hypoxaemia is needed to stimulate erythropoietin release and initiate an increase in red cell mass.
Other factors may also be important in the generation of polycythaemia. In patients with chronic obstructive lung disease carboxyhaemoglobin is the only variable that has been shown to correlate with erythropoietin concentration,6 and there is a clear association between cigarette smoking and polycythaemia in this condition.'0 Patients with sleep hypoxaemia often have low testosterone concentrations,11 and as androgens stimulate erythropoiesis by an unknown mechanism androgen deficiency associated with obstructive sleep apnoea is possibly responsible for a reduction in erythropoietin production.
In conclusion, we did not find raised erythropoietin concentrations in patients with obstructive sleep apnoea and recurrent short episodes of severe nocturnal hypoxaemia. We suggest that prolonged episodes of nocturnal hypoxaemia may be necessary to stimulate erythropoietin production. These findings may explain why polycythaemia is uncommon in patients with obstructive sleep apnoea.
